Q: Savaria coming out with earnings next week. Do you think we will get some news
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I am looking for US Healthcare ETF. What do you recommend?
Q: What do you think of KERX? Thanks.
Q: Hi 5i,
The after hours trading (Feb 28th) on SRPT was ugly following their report. A big miss on expectations but they were expected to lose money and I can’t tell what the expectations themselves might have been based on. I know you may not be overly familiar, as it is a US stock, but can you help size it up? I'm wondering if it is real trouble or maybe an over-reaction opportunity once things settle down a bit. Thanks!
The after hours trading (Feb 28th) on SRPT was ugly following their report. A big miss on expectations but they were expected to lose money and I can’t tell what the expectations themselves might have been based on. I know you may not be overly familiar, as it is a US stock, but can you help size it up? I'm wondering if it is real trouble or maybe an over-reaction opportunity once things settle down a bit. Thanks!
Q: hi Guys,
Can I please get your opinion of Extendicare's latest results.
Thanks
Dave
Can I please get your opinion of Extendicare's latest results.
Thanks
Dave
Q: For a little penny stock fun, I purchased Medx Health last year for 12 cents. It went well into 20's, but has now retreated to 12. would very much appreciate your professional review/assessment
Q: Hi 5i,
Looking to add a specialty pharmaceutical with growth potential in a TFSA. Willing to wait for the growth and am comfortable with the risk. Morningstar rates both of these as 'undervalued' currently. Which do you prefer for future growth prospects? Thank-you.
Looking to add a specialty pharmaceutical with growth potential in a TFSA. Willing to wait for the growth and am comfortable with the risk. Morningstar rates both of these as 'undervalued' currently. Which do you prefer for future growth prospects? Thank-you.
Q: Hi, Savaria price has declined sharply over last 3 trading sessions on large volume. Any insight/comments ? Thanks
Q: You state that the stock is cheap based on certain metrics.Please elaborate.
-
BMO Equal Weight US Health Care Hedged to CAD Index ETF (ZUH)
-
Harvest Healthcare Leaders Income ETF (HHL)
Q: What is your opinion on HHL
Q: Good morning,
I've been hearing for a while how expensive sis is and how undervalued crh is. Can you comment. And also do you think now after the drop in sis and rise in crh that they are both buys today?
Thank you.
I've been hearing for a while how expensive sis is and how undervalued crh is. Can you comment. And also do you think now after the drop in sis and rise in crh that they are both buys today?
Thank you.
Q: Endo is still making money but the share price has dropped about 80 percent and they have a high debt load. How aggressively will they persue selling assets to lower the debt load and are repayments in the near future a concern? I do not own Endo but do own Knight and I was a shareholder in Palladin. THANKYOU
Q: Hello 5i,
I don't have much healthcare exposure right now but I'm thinking about getting back in. I noticed the resent many reasonably priced options in Canada - CRH and GUD seem like the go to names but each have massive P/E ratios.
As a result, I was thinking about buying a US retail pharma stock like CVS or just buying the XLV instead. I like CVS as it is kinda like "owning the race track instead of the the race car". Am I hitting the mark with this analogy or am I missing something? Some Bio tech names appear quite cheap due to pricing/political risk etc. But I also would never know which one to buy. Do you see any issues with the CVS in general? Would you recommend just buying the XLV instead? Thanks
I don't have much healthcare exposure right now but I'm thinking about getting back in. I noticed the resent many reasonably priced options in Canada - CRH and GUD seem like the go to names but each have massive P/E ratios.
As a result, I was thinking about buying a US retail pharma stock like CVS or just buying the XLV instead. I like CVS as it is kinda like "owning the race track instead of the the race car". Am I hitting the mark with this analogy or am I missing something? Some Bio tech names appear quite cheap due to pricing/political risk etc. But I also would never know which one to buy. Do you see any issues with the CVS in general? Would you recommend just buying the XLV instead? Thanks
Q: Hi,
Any idea when GUD will be announcing earnings?
Thanks!
Any idea when GUD will be announcing earnings?
Thanks!
Q: I would appreciate if you can provide your thoughts about Neptune. What are their strengths and weaknesses. would you consider the stock a buy at this level.
Q: Can you provide insight on CRH Medical? Cantor Fitzgerald has a $7.00 target price. Looks interesting.
Thank you
Marty
Thank you
Marty
Q: I have been thinking about adding medical services to my portfolio.
There are several, in your opinion which one would you be better for the long term and dividend.
John
There are several, in your opinion which one would you be better for the long term and dividend.
John
Q: Can we get your opinion on TH with regards to:
- financial results announced Feb.8/17
- results of recent tests of their product
- is their a chance this company could become a portfolio changer, I mean should I average up and take this to a 3% position from 1.5%
Thanks for your great service as I would likely not heard of a company like TH without being a member
- financial results announced Feb.8/17
- results of recent tests of their product
- is their a chance this company could become a portfolio changer, I mean should I average up and take this to a 3% position from 1.5%
Thanks for your great service as I would likely not heard of a company like TH without being a member
Q: Prometic: you are probably up to speed on this one by now but do not see anything on the Q&A section. But California Capital Equity picked up 44M shares ... warrants at 0.47 cents. Dumb questions looking at the drop in price today (-7%). I am assuming this is not looked upon favourably?
Q: Regarding PLI's drop, if there is no apparent reason, does it indicate that the stock is being manipulated in some way? Does a halt like this with no apparent reason for the drop concern 5i as it is one of your "holdings"?